AI-generated summary
The authors report a double-blind randomized trial in four Canadian centers comparing 10,000-lux light therapy with a placebo capsule against 100-lux placebo light with fluoxetine in patients with winter seasonal depression. They found no overall differences in response or remission rates, with light showing earlier improvement at one week and fewer certain side effects. The study lacked a double-placebo condition, which the authors note as a limitation.
- Participants
- 96
- Who or what was studied
- Patients with major depressive disorder with a winter seasonal pattern (DSM-IV criteria) and Hamilton Depression Rating Scale scores of 23 or higher, enrolled across four Canadian centers over three winter seasons
- Limits stated in the abstract
- The study was limited by the lack of a double-placebo condition, and the early-response difference was a post hoc finding.
Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.
Abstract
The full abstract is not shown here because it is protected by the publisher’s copyright. Read it on psychiatryonline.org.
Record from PubMed, a service of the National Library of Medicine.
How to read a trial: what to check before relying on this kind of research.
Terms in this paper: Randomized controlled trial, Lux, Depression. Each links to its definition in the glossary.
A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.